ORMP — Oramed Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Oramed Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 August 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	94.1	156	162	142	126
Prepaid Expenses
Total Other Current Assets
Total Current Assets	95.3	157	163	143	133
Net Property, Plant And Equipment	0.93	1.8	1.57	1.11	1.34
Long Term Investments
Other Long Term Assets
Total Assets	128	162	221	155	231
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	6.68	5.75	53.2	5.68	19.1
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	12.2	9.83	56.7	9.01	31.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	116	152	164	146	200
Total Liabilities & Shareholders' Equity	128	162	221	155	231
Total Common Shares Outstanding